10.01.2020 • News

ISPE Appoints Tim Howard as Acting CEO and President

The International Society for Pharmaceutical Engineering (ISPE) has appointed...
The International Society for Pharmaceutical Engineering (ISPE) has appointed Tim Howard as the organization’s acting CEO and president. © ISPE

The International Society for Pharmaceutical Engineering (ISPE) has appointed Tim Howard as the organization’s acting CEO and president. John Bournas, the former CEO and president, stepped down from his position effective Jan. 8, 2020. Howard has taken a leave of absence from his current industry position and will lead the ISPE team under the direction of the ISPE Board until a permanent replacement will be found.

Before taking on the role as acting CEO and president of ISPE, Howard has held various senior roles at Commissioning Agents Inc. (CAI), most recently as vice president Human Resources. From 2011 to 2019, he was a member of the international board of directors of ISPE, serving as chair in 2018. Howard holds a B.S. degree in Mechanical Engineering from North Carolina State University.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

29 April 2026 | This webinar explores how chemical industry organizations can design a digital‑ and AI‑ready operating model focused on clarity, usability, and measurable value.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.